logo
logo
Sign in

Metagenomic Sequencing Market Value Along with Future Market Value Expectation

avatar
Vinit Sawant

Overview

The metagenomic sequencing market is projected to grow at a CAGR of 6.5% during the forecast period 2017 to 2023. As per the metagenomic sequencing market research report, the global market for metagenomic sequencing is projected to grow rapidly. According to analysts, the rising awareness about genetic disorders as well as advanced technological platforms will drive the market growth during the forecast period 2017 to 2023.

The metagenomic sequencing market research report offers a comprehensive analysis of the global metagenomic sequencing market and its application, end user, and technology segments. The lack of resources, lack of skilled professionals along with high cost of developing the specific infrastructure are the elements that could influence the metagenomic sequencing market advancement throughout the forecast period 2017 to 2023. The metagenomic sequencing market research report by the healthcare industry’s expert analysts is developed to assist organizations in the metagenomic sequencing market.

Regional Overview

North America, Europe, Asia Pacific and the rest of the world regional market for metagenomic sequencing are predominantly covered in the global metagenomic sequencing market research report. Country-level metagenomic sequencing markets spread across North America – the United States, Canada, and Mexico are also covered in the report. In South America – Brazil and other country-level metagenomic sequencing markets are covered in the report.

In Asia-Pacific (APAC) region, the country-level metagenomic sequencing markets covered are Japan, India, China, and others. The metagenomic sequencing market research report also explores the regional market for metagenomic sequencing present in Europe in the United Kingdom, France, Italy, Spain, and Germany, etc. The metagenomic sequencing market research report also covers regional markets from the rest of the world alongside metagenomic sequencing markets of Africa and the Middle East.

Industry News

Australian microbial genetic engineering company Microba has announced its partnership with Queensland University to research gut-microbiome to discover new biomarkers and therapies to cure Parkinson. Analysis has correlated changes in the intestinal microbiota with the onset of Parkinson's disease, according to Microba. Under the terms of this partnership, the University of Queensland and Microba will investigate the link between gut microbiome and Parkinson's disease in animal models and in patients using the company's metagenomic sequencing and analysis technologies.

 

collect
0
avatar
Vinit Sawant
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more